Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Current Period Unaudited)

v3.22.2.2
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 9,293 $ 8,137
Accounts receivable 94 269
Lease receivable, current portion 15,811 920
Inventory 28 123
Assets held for sale 1,100 2,633
Prepaid expenses and other current assets 375 356
Total current assets 26,701 12,438
Non-current assets    
Property and equipment, net 4,629 2,367
Intellectual property, net 505 640
Investment in LINICO 2,000 1,500
Lease receivable, non-current portion 0 15,528
Other assets 1,126 796
Total non-current assets 8,260 20,831
Total assets 34,961 33,269
Current liabilities    
Accounts payable 867 685
Accrued expenses 2,863 3,005
Lease liability, current portion 302 388
Building purchase deposit, current portion 1,250 0
Notes payable 5,886 0
Total current liabilities 11,168 4,078
Non-current liabilities    
Building purchase deposit, non-current portion 0 1,328
Lease liability, non-current portion 350 330
Total liabilities 11,518 5,736
Commitments and contingencies (see Note 13)
Stockholders’ equity    
Common stock; $0.001 par value; 200,000,000 shares authorized; 78,065,455 and 70,416,552 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively 78 70
Additional paid-in capital 218,672 211,309
Accumulated deficit (195,307) (183,846)
Total stockholders’ equity 23,443 27,533
Total liabilities and stockholders’ equity $ 34,961 $ 33,269